Finance

Lists
BXP:LON
Beximco Pharmaceuticals GDR
51,16 GBX
-0,67%
(-0,35) 1D
12-окт., 16:30:00 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for BXP...
Open
51,03 GBX
High
52,64 GBX
Low
51,03 GBX
Avg. vol.
23,56 миң
Volume
4,67 миң
52-wk high
65,00 GBX
52-wk low
36,70 GBX
Shares outstanding
405,56 млн
No. of employees
1 миң
Open
51,03 GBX
High
52,64 GBX
Low
51,03 GBX
Avg. vol.
23,56 миң
Volume
4,67 миң
52-wk high
65,00 GBX
52-wk low
36,70 GBX
Shares outstanding
405,56 млн
No. of employees
1 миң
News stories
From web sources and news partners
About Beximco Pharmaceuticals GDR
CEO-
Employees1,22 миң
Founded1976
HeadquartersДака, Dhaka District, Бангладеш
SectorPharmaceutical industry
Previous reportsAll values in BDT
Loading Previous Earnings...
Revenue
Net income
All values in BDT
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
12,50 млд
13,79 млд
14,01 млд
13,63 млд
Cost of goods sold
7,17 млд
7,16 млд
7,05 млд
6,93 млд
Cost of revenue
7,17 млд
7,16 млд
7,05 млд
6,93 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,10 млд
3,50 млд
3,84 млд
3,84 млд
Operating expense
3,10 млд
3,50 млд
3,84 млд
3,84 млд
Total operating expenses
10,27 млд
10,66 млд
10,90 млд
10,77 млд
Operating income
2,23 млд
3,14 млд
3,11 млд
2,86 млд
Other non operating income
113,91 млн
129,13 млн
203,65 млн
193,27 млн
EBT including unusual items
2,17 млд
3,12 млд
3,12 млд
2,91 млд
EBT excluding unusual items
2,13 млд
3,12 млд
3,12 млд
2,91 млд
Income tax expense
427,45 млн
718,41 млн
732,06 млн
652,35 млн
Effective tax rate
19,74%
23,03%
23,43%
22,44%
Other operating expenses
-
-
-
-
Net income
1,71 млд
2,36 млд
2,36 млд
2,22 млд
Net profit margin
13,67%
17,13%
16,83%
16,29%
Earnings per share
-
-
-
-
Interest and investment income
27,30 млн
39,60 млн
-
-
Interest expense
-161,48 млн
-186,31 млн
-187,24 млн
-146,06 млн
Net interest expenses
-134,17 млн
-146,71 млн
-187,24 млн
-146,06 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
2,42 млд
3,62 млд
3,68 млд
3,39 млд
Gain or loss from assets sale
-29,40 млн
111,00 миң
-9,16 млн
-4,92 млн
AI content may include mistakes. Learn more
Google колдонмолору